JANX- Janux Therapeutics, Inc.

Name: Janux Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Janux Therapeutics, Inc. (JANX) has 13 insiders with recent SEC Form 4 filings, including 4 buys and 16 sells. JANX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Campbell David Alan	285.0K	$4.05M	-
Other	Diraimondo Thomas	155.8K	$2.22M	-
Other	Winter Charles M.	106.3K	$1.51M	-
Other	Meyer Andrew Hollman	83.1K	$1.18M	-
Dir	Capps Vickie L	79.6K	$1.13M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 9, 2024	Avalon Ventures Xi, L.P.80	-	Sale+OE	242,182	$42.00	$10,172,364.06	-3.3%	+47.3%	-43.2%
Jun 3, 2024	Reardon Tighe71	Acting Chief Financial Officer	Sell	822,721	$54.75	$45,043,974.75	-17.2%	-18.1%	-53.7%
Jun 3, 2024	Lichter Jay70	Director, 10% Owner	Sell	1,500,000	$54.75	$82,125,000.00	-17.2%	-18.1%	-53.7%
Jun 3, 2024	Avalon Ventures Xi, L.P.80	10% Owner	Sell	1,500,000	$54.75	$82,125,000.00	-17.2%	-18.1%	-53.7%
Nov 13, 2023	Lichter Jay70	Director, 10% Owner	Buy	849,854	$5.87	$4,988,642.98	New	+21.4%	+645.3%
Nov 13, 2023	Reardon Tighe71	Acting Chief Financial Officer	Buy	849,854	$5.87	$4,988,642.98	New	+21.4%	+645.3%
Nov 13, 2023	Avalon Ventures Xi, L.P.80	10% Owner	Buy	849,854	$5.87	$4,988,642.98	New	+21.4%	+645.3%
Jul 19, 2023	Ra Capital Management, L.P.53	Director, 10% Owner	Buy	495,008	$12.46	$6,167,799.68	+6.5%	-38.2%	+239.2%
Dec 29, 2021	Thompson Peter A.65	Director	Sell	40,400	$20.30	$820,120.00	-1.6%	-27.6%	-31.9%
Dec 29, 2021	Orbimed Advisors LLC67	Director	Sell	40,400	$20.30	$820,120.00	-1.6%	-27.6%	-31.9%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC